Literature DB >> 24247370

A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin.

Seza Ozen1, Yelda Bilginer1.   

Abstract

Autoinflammatory diseases are associated with abnormal activation of the innate immune system, leading to clinical inflammation and high levels of acute-phase reactants. The first group to be identified was the periodic fever diseases, of which familial Mediterranean fever (FMF) is the most common. In FMF, genetic results are not always straightforward; thus, flowcharts to guide the physician in requesting mutation analyses and interpreting the findings are presented in this Review. The other periodic fever diseases, which include cryopyrin-associated periodic syndromes (CAPS), TNF receptor-associated periodic syndrome (TRAPS) and mevalonate kinase deficiency/hyperimmunoglobulin D syndrome (MKD/HIDS), have distinguishing features that should be sought for carefully during diagnosis. Among this group of diseases, increasing evidence exists for the efficacy of anti-IL-1 treatment, suggesting a major role of IL-1 in their pathogenesis. In the past decade, we have started to learn about the other rare autoinflammatory diseases in which fever is less pronounced. Among them are diseases manifesting with pyogenic lesions of the skin and bone; diseases associated with granulomatous lesions; diseases associated with psoriasis; and diseases associated with defects in the immunoproteasome. A better understanding of the pathogenesis of these autoinflammatory diseases has enabled us to provide targeted biologic treatment at least for some of these conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247370     DOI: 10.1038/nrrheum.2013.174

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  101 in total

1.  Pyrin Q148 mutation and familial Mediterranean fever.

Authors:  S Ozen; N Besbas; A Bakkaloglu; E Yilmaz
Journal:  QJM       Date:  2002-05

2.  Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Authors:  Andrew P Demidowich; Alexandra F Freeman; Douglas B Kuhns; Ivona Aksentijevich; John I Gallin; Maria L Turner; Daniel L Kastner; Steven M Holland
Journal:  Arthritis Rheum       Date:  2011-12-12

3.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

4.  Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.

Authors:  Ariel C Bulua; Douglas B Mogul; Ivona Aksentijevich; Harjot Singh; David Y He; Larry R Muenz; Michael M Ward; Cheryl H Yarboro; Daniel L Kastner; Richard M Siegel; Keith M Hull
Journal:  Arthritis Rheum       Date:  2012-03

5.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Authors:  Jae Jin Chae; Young-Hun Cho; Geun-Shik Lee; Jun Cheng; P Paul Liu; Lionel Feigenbaum; Stephen I Katz; Daniel L Kastner
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

6.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

7.  NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.

Authors:  Juan I Aróstegui; Cristina Arnal; Rosa Merino; Consuelo Modesto; María Antonia Carballo; Purificación Moreno; Julia García-Consuegra; Antonio Naranjo; Eduardo Ramos; Pilar de Paz; Josefa Rius; Susana Plaza; Jordi Yagüe
Journal:  Arthritis Rheum       Date:  2007-11

8.  Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children.

Authors:  Seza Ozen; Erkan Demirkaya; Gayane Amaryan; Isabelle Koné-Paut; Adem Polat; Pat Woo; Yosef Uziel; Consuelo Modesto; Martina Finetti; Pierre Quartier; Efimia Papadopoulou-Alataki; Sulaiman M Al-Mayouf; Giovanna Fabio; Romina Gallizzi; Luca Cantarini; Joost Frenkel; Susan Nielsen; Michael Hofer; Antonella Insalaco; C Acikel; Huri Ozdogan; Alberto Martini; Nicolino Ruperto; Marco Gattorno
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

9.  Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura.

Authors:  Ruth Gershoni-Baruch; Yiftah Broza; Riva Brik
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

10.  Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  Kazuki Takada; Ivona Aksentijevich; Vijayabhanu Mahadevan; Jane A Dean; Richard I Kelley; Daniel L Kastner
Journal:  Arthritis Rheum       Date:  2003-09
View more
  71 in total

Review 1.  Autoinflammatory Syndromes in Children.

Authors:  Ruth J Pepper; Helen J Lachmann
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

Review 2.  Autoinflammatory Diseases with Periodic Fevers.

Authors:  Erdal Sag; Yelda Bilginer; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 3.  The myths we believed in familial Mediterranean fever: what have we learned in the past years?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Semin Immunopathol       Date:  2015-04-02       Impact factor: 9.623

4.  Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.

Authors:  S Tsuji; H Matsuzaki; M Iseki; A Nagasu; H Hirano; K Ishihara; N Ueda; Y Honda; T Horiuchi; R Nishikomori; Y Morita; T Mukai
Journal:  Clin Exp Immunol       Date:  2019-09-04       Impact factor: 4.330

5.  Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.

Authors:  Fehime Kara Eroglu; Nesrin Beşbaş; Rezan Topaloglu; Seza Ozen
Journal:  Rheumatol Int       Date:  2015-05-23       Impact factor: 2.631

Review 6.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 7.  Assembly and regulation of ASC specks.

Authors:  Florian Hoss; Juan F Rodriguez-Alcazar; Eicke Latz
Journal:  Cell Mol Life Sci       Date:  2016-10-19       Impact factor: 9.261

8.  TNF-α/TNFR1 signaling is required for the development and function of primary nociceptors.

Authors:  Michael A Wheeler; Danielle L Heffner; Suemin Kim; Sarah M Espy; Anthony J Spano; Corey L Cleland; Christopher D Deppmann
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

Review 9.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

10.  Evaluation of the international severity score for FMF (ISSF) scores in Turkish children diagnosed with FMF: a single-center experience.

Authors:  Fatih Mehmet Akif Özdemir; Nesrin Gülez; Balahan Makay
Journal:  Clin Rheumatol       Date:  2021-02-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.